ARS PHARMACEUTICALS INC
SPRY · NASDAQ
Updated at 2026-10-15 08:40:05
- Today's High
- $4.09
- Today’s Low
- $3.88
%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23150%3B%26%23135%3B%26%23230%3B%26%23161%3B%26%23163%3B%26%23230%3B%26%23154%3B%26%23151%3B%26%23232%3B%26%23167%3B%26%23146%3B%22%20d%3D%22M48.3363%2013.4132H60.2082L46.795%205.72205e-06V11.8719C46.795%2012.7231%2047.4851%2013.4132%2048.3363%2013.4132Z%22%20fill%3D%22var(--fill-0%2C%20%23474741)%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23148%3B%26%23190%3B%26%23229%3B%26%23164%3B%26%23167%3B%26%23233%3B%26%23149%3B%26%23156%3B%22%20fill-rule%3D%22evenodd%22%20clip-rule%3D%22evenodd%22%20d%3D%22M11.3812%2020.3725C16.7977%2014.9559%2025.5803%2014.9559%2030.9969%2020.3725C36.413%2025.789%2036.4131%2034.5707%2030.9969%2039.9872C26.0109%2044.973%2018.1729%2045.3699%2012.7335%2041.1769L2.54298%2051.3684L0%2048.8254L10.1915%2038.6329C5.99993%2033.1937%206.39609%2025.3579%2011.3812%2020.3725ZM28.4539%2022.9155C24.4418%2018.9033%2017.9363%2018.9033%2013.9241%2022.9155C9.91245%2026.9275%209.91241%2033.4322%2013.9241%2037.4442C17.9362%2041.4562%2024.4418%2041.4562%2028.4539%2037.4442C32.4656%2033.4322%2032.4656%2026.9275%2028.4539%2022.9155Z%22%20fill%3D%22var(--fill-0%2C%20%235D5D56)%22%2F%3E%0A%3C%2Fg%3E%0A%20%20%3C%2Fsvg%3E%0A%3C%2Fsvg%3E%0A)
Candlestick trends are for reference. Refer to the trading page for actual data.
Key Statistics
- Previous Open
- $4.01
- Previous Close
- $3.93
- Volume
- 1.72M
- Market Cap
- $390.82M
- P/E Ratio
- --
- EPS
- $-2.17
Previous Day Range
52-Week Range
Company Overview
- Sector
- HEALTHCARE
- Industry
- Biotechnology
- Sub-industry
- BIOTECHNOLOGY
- Headquarters
- 11682 EL CAMINO REAL, SAN DIEGO, CA, UNITED STATES, 92130
- Country
- US
- Listing Date
- 2020-12-04
- Fiscal Year End
- December
- Shares Outstanding
- 99.3M
- CIK
- 0001671858
- Website
- ars-pharma.com
ARS Pharmaceuticals, Inc. develops ARS-1, a novel intranasal epinephrine aerosol with absorption technology for patients and their families at risk of severe allergic reactions to food, medication, and insect stings. The company is headquartered in San Diego, California.
Financial Metrics
Revenue
2026-06-30
$33.65M
2026-03-31
$22.68M
2025-12-31
$28.08M
2025-09-30
$32.5M
Operating Expenses
2026-06-30
$82.27M
2026-03-31
$76.54M
2025-12-31
$66.35M
2025-09-30
$77.5M
Net Income
2026-06-30
-$62.33M
2026-03-31
-$60.61M
2025-12-31
-$41.32M
2025-09-30
-$51.15M
Net Profit Margin
2026-06-30
-185.21%
2026-03-31
-267.26%
2025-12-31
-147.12%
2025-09-30
-157.38%
Earnings Per Share
2026-06-30
$-0.63
2026-03-31
$-0.61
2025-12-31
$-0.42
2025-09-30
$-0.52
Earnings Before Interest, Taxes, Depreciation, and Amortization
2026-06-30
-$59.44M
2026-03-31
-$57.78M
2025-12-31
-$40.98M
2025-09-30
-$48.79M
Effective Tax Rate
2026-06-30
--
2026-03-31
--
2025-12-31
0.19%
2025-09-30
--
| Item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
| Revenue | $33.65M | $22.68M | $28.08M | $32.5M |
| Operating Expenses | $82.27M | $76.54M | $66.35M | $77.5M |
| Net Income | -$62.33M | -$60.61M | -$41.32M | -$51.15M |
| Net Profit Margin | -185.21% | -267.26% | -147.12% | -157.38% |
| Earnings Per Share | $-0.63 | $-0.61 | $-0.42 | $-0.52 |
| Earnings Before Interest, Taxes, Depreciation, and Amortization | -$59.44M | -$57.78M | -$40.98M | -$48.79M |
| Effective Tax Rate | -- | -- | 0.19% | -- |
FAQs
Risk Warning
Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations.